Aetna Inc. (NYSE:AET) – Stock analysts at Oppenheimer Holdings decreased their Q1 2018 earnings per share (EPS) estimates for shares of Aetna in a research note issued on Tuesday. Oppenheimer Holdings analyst M. Wiederhorn now anticipates that the company will post earnings per share of $2.75 for the quarter, down from their prior forecast of $2.76. Oppenheimer Holdings also issued estimates for Aetna’s Q3 2018 earnings at $2.67 EPS.

Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.06 by $0.39. The business had revenue of $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The firm’s quarterly revenue was down 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.07 EPS.

TRADEMARK VIOLATION NOTICE: “Oppenheimer Holdings Weighs in on Aetna Inc.’s Q1 2018 Earnings (AET)” was first reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The legal version of this report can be accessed at https://www.watchlistnews.com/oppenheimer-holdings-weighs-in-on-aetna-inc-s-q1-2018-earnings-aet/1678058.html.

Several other research analysts have also commented on AET. Credit Suisse Group restated an “outperform” rating and set a $165.00 price target (up previously from $160.00) on shares of Aetna in a research note on Thursday, July 13th. Deutsche Bank AG raised their target price on shares of Aetna from $144.00 to $157.00 and gave the company a “hold” rating in a research note on Thursday, July 13th. BidaskClub lowered shares of Aetna from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Royal Bank Of Canada raised their price target on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a research report on Friday, August 4th. Finally, Jefferies Group LLC restated a “hold” rating and issued a $163.00 price target (up from $157.00) on shares of Aetna in a research report on Friday, August 4th. Eleven research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $168.78.

Shares of Aetna (NYSE:AET) opened at $176.99 on Thursday. The stock has a market capitalization of $56.19 billion, a PE ratio of 16.88, a P/E/G ratio of 1.57 and a beta of 0.61. The company has a current ratio of 0.53, a quick ratio of 0.48 and a debt-to-equity ratio of 0.52.

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were given a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, October 11th. This represents a $2.00 annualized dividend and a yield of 1.13%. Aetna’s payout ratio is currently 37.04%.

In related news, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now owns 64,261 shares in the company, valued at $10,404,498.51. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the sale, the executive vice president now directly owns 33,563 shares in the company, valued at $5,465,734.55. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AET. BlackRock Inc. lifted its holdings in shares of Aetna by 3,374.9% during the first quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock valued at $3,917,344,000 after purchasing an additional 29,828,390 shares in the last quarter. FMR LLC lifted its holdings in Aetna by 73.8% in the second quarter. FMR LLC now owns 13,736,800 shares of the company’s stock valued at $2,085,659,000 after acquiring an additional 5,833,567 shares during the period. Janus Henderson Group PLC lifted its holdings in Aetna by 9,446.2% in the second quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock valued at $657,255,000 after acquiring an additional 4,283,553 shares during the period. Capital World Investors raised its stake in shares of Aetna by 8.9% in the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after buying an additional 1,688,767 shares during the period. Finally, Vanguard Group Inc. raised its stake in shares of Aetna by 3.8% in the first quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock worth $2,948,640,000 after buying an additional 838,578 shares during the period. 89.45% of the stock is currently owned by hedge funds and other institutional investors.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Earnings History and Estimates for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.